CRITCHLEY, STEPHEN,GANT, THOMAS G.,LANGSTON, STEVEN P.,OLHAVA, EDWARD J.,PELUSO, STEPHANE
申请号:
CA2596424
公开号:
CA2596424C
申请日:
2006.02.02
申请国别(地区):
CA
年份:
2016
代理人:
摘要:
This invention relates to compounds of the general formula I-A orpharmaceuticallyacceptable salts thereof, that inhibit E1 activating enzymes, pharmaceuticalcompositionscomprising the compounds, and methods of using the compounds. The compoundsareuseful for treating disorders, particularly cell proliferation disorders,including cancers,inflammatory and neurodegenerative disorders; and inflammation associated withinfection and cachexia.(see above formula)